TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CAI

Caris Life Sciences, Inc.

Healthcare · Biotechnology · —

32.00$ -0.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Caris Life Sciences, Inc. (CAI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,230 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CAI
Line item Q2 21 Q3 21 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,955 3,266 – – – 344 292 955 985 1,126 1,162 1,230
211 243 – – – 216 171 833 854 998 1,014 1,058
39 47 122 – – 64 31 719 753 798 821 691
39 47 122 – – 66 33 721 755 800 823 793
166 191 – – – 88 80 51 27 112 91 117
– – – – – 40 37 41 49 64 76 124
– – – – – 19 19 19 19 19 19 19
2,199 2,466 20 – – 621 2,891 502 506 548 569 638
467 338 – – – 165 163 90 86 127 144 191
116 162 – – – 66 66 7.4 6.6 0.2 6.0 6.5
4.4 3.4 – – – 28 24 29 29 39 70 86
– – – – – – 317 374 376 378 381 393
756 801 -20 – – -277 -2,600 453 478 577 593 592
562 606 – – – -2,472 -2,583 -2,655 -2,631 -2,549 -2,549 -2,550
17 18 255 255 281 281 255 276 297 290 283 283

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?